Molecular Matrix Enters Alliance to Expand Bone Graft Availability in Asia

Molecular Matrix (MMI) signed a Memorandum of Understanding with Philosys Healthcare to expand availability of next-generation bone graft substitute technology in Asia.

MMI has developed a scaffold for bone tissue regeneration based on synthetically hyper-crosslinked carbohydrate polymer (HCCP) chains that are non-immunogenic, biocompatible,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us